Przemysław Bieńkowski

4.2k total citations
177 papers, 3.2k citations indexed

About

Przemysław Bieńkowski is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Przemysław Bieńkowski has authored 177 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cellular and Molecular Neuroscience, 35 papers in Molecular Biology and 31 papers in Psychiatry and Mental health. Recurrent topics in Przemysław Bieńkowski's work include Neurotransmitter Receptor Influence on Behavior (57 papers), Neuroscience and Neuropharmacology Research (45 papers) and Biochemical Analysis and Sensing Techniques (26 papers). Przemysław Bieńkowski is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (57 papers), Neuroscience and Neuropharmacology Research (45 papers) and Biochemical Analysis and Sensing Techniques (26 papers). Przemysław Bieńkowski collaborates with scholars based in Poland, United States and Germany. Przemysław Bieńkowski's co-authors include Wojciech Kostowski, Eliza Koroś, Jerzy Samochowiec, Paweł Mierzejewski, Anna Ścińska, Halina Sienkiewicz‐Jarosz, Marcin Kołaczkowski, Roman Stefański, Agnieszka Samochowiec and Agnieszka Korkosz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stroke and Brain Research.

In The Last Decade

Przemysław Bieńkowski

172 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Przemysław Bieńkowski Poland 31 1.5k 842 557 407 357 177 3.2k
Andrew J. Goudie United Kingdom 31 1.7k 1.1× 633 0.8× 652 1.2× 238 0.6× 478 1.3× 94 3.2k
László Lénárd Hungary 26 1.2k 0.8× 621 0.7× 636 1.1× 462 1.1× 165 0.5× 141 2.9k
Vijay A. Ramchandani United States 39 1.7k 1.1× 570 0.7× 785 1.4× 298 0.7× 169 0.5× 173 4.9k
Annette L. Kirchgessner United States 38 1.1k 0.8× 1.2k 1.4× 684 1.2× 367 0.9× 253 0.7× 67 4.6k
Edwin Zvartau Russia 32 2.1k 1.4× 1.3k 1.5× 690 1.2× 204 0.5× 354 1.0× 151 5.3k
John R. Glowa United States 36 2.8k 1.9× 1.5k 1.7× 704 1.3× 291 0.7× 227 0.6× 96 4.4k
Andrew Harkin Ireland 42 1.3k 0.9× 857 1.0× 283 0.5× 141 0.3× 518 1.5× 122 4.9k
John E. McGeary United States 31 796 0.5× 450 0.5× 557 1.0× 156 0.4× 336 0.9× 95 3.3k
Gregg D. Stanwood United States 39 2.0k 1.4× 1.7k 2.0× 617 1.1× 225 0.6× 301 0.8× 80 4.6k
Luis Hernández Venezuela 24 1.2k 0.8× 618 0.7× 388 0.7× 268 0.7× 204 0.6× 71 2.3k

Countries citing papers authored by Przemysław Bieńkowski

Since Specialization
Citations

This map shows the geographic impact of Przemysław Bieńkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Przemysław Bieńkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Przemysław Bieńkowski more than expected).

Fields of papers citing papers by Przemysław Bieńkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Przemysław Bieńkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Przemysław Bieńkowski. The network helps show where Przemysław Bieńkowski may publish in the future.

Co-authorship network of co-authors of Przemysław Bieńkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Przemysław Bieńkowski. A scholar is included among the top collaborators of Przemysław Bieńkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Przemysław Bieńkowski. Przemysław Bieńkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bieńkowski, Przemysław, et al.. (2024). Mental healthcare and addiction services in Poland: a (hi)story of attraction and rejection. International Review of Psychiatry. 37(3-4). 271–282. 1 indexed citations
2.
Bieńkowski, Przemysław & Adam Wichniak. (2024). Efficacy and tolerability of brexpiprazole – a new antipsychotic drug from the group of dopamine D2 receptor partial agonists. Psychiatria Polska. 58(2). 237–248. 1 indexed citations
3.
Samochowiec, Jerzy, Dorota Frydecka, Karolina Skonieczna‐Żydecka, et al.. (2023). Ethical dilemmas in contemporary psychiatry: Findings from a survey of National Psychiatric Associations in Europe. European Psychiatry. 66(1). e94–e94. 3 indexed citations
4.
Wroński, Michał, et al.. (2022). Deficit Symptomatology of Schizophrenia Is Associated with Attenuated Taste Identification: Findings from a Cross-Sectional Study. Brain Sciences. 12(11). 1520–1520. 2 indexed citations
5.
Rogowski, Artur, Tomasz Kluz, Andrzej Wróbel, et al.. (2021). Psychiatric History and Overactive Bladder Symptom Severity in Ambulatory Urogynecological Patients. Journal of Clinical Medicine. 10(17). 3988–3988. 2 indexed citations
6.
Wichniak, Adam, Marcin Siwek, Joanna Rymaszewska, et al.. (2021). The position statement of the Working Group of the Polish Psychiatric Association on the use of D2/D3 dopamine receptor partial agonists in special populations. Psychiatria Polska. 55(5). 967–987. 5 indexed citations
7.
Samochowiec, Jerzy, Agata Szulc, Przemysław Bieńkowski, et al.. (2021). Polish Psychiatric Association consensus statement on non-pharmacological methods in the treatment of negative symptoms of schizophrenia. Psychiatria Polska. 55(4). 719–742. 1 indexed citations
8.
Kaczmarczyk, Mariusz, Błażej Misiak, Michał Wroński, et al.. (2020). Analysis of gut microbiota and intestinal integrity markers of inpatients with major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 106. 110076–110076. 62 indexed citations
9.
Bieńkowski, Przemysław, et al.. (2020). Potential underdiagnosis of somatic comorbidity in patients with schizophrenia and with bipolar disorder. 1 indexed citations
10.
Wichniak, Adam, Dominika Dudek, Janusz Heitzman, et al.. (2019). Metabolic risk reduction in patients with schizophrenia treated with antipsychotics: recommendations of the Polish Psychiatric Association. Psychiatria Polska. 53(6). 1191–1218. 12 indexed citations
11.
Krenke, Rafał, Joanna Chorostowska‐Wynimko, Marta Dąbrowska, et al.. (2018). Management of cough in adults – recommendations for family physicians. 4(6). 425–452. 1 indexed citations
12.
Doniec, Zbigniew, Agnieszka Mastalerz–Migas, Katarzyna Krenke, Henryk Mazurek, & Przemysław Bieńkowski. (2016). Rekomendacje postępowania diagnostyczno-terapeutycznego w kaszlu u dzieci dla lekarzy POZ. 2(4). 305–321. 1 indexed citations
13.
Więckowska, Anna, Marcin Kołaczkowski, Adam Bucki, et al.. (2016). Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry. 124. 63–81. 74 indexed citations
14.
Rogowski, Artur, et al.. (2015). Retrospective comparison between the Prolift and Elevate anterior vaginal mesh procedures: 18-month clinical outcome. 3 indexed citations
15.
Pełka-Wysiecka, Justyna, et al.. (2015). Odors identification differences in deficit and nondeficit schizophrenia. Pharmacological Reports. 68(2). 390–395. 10 indexed citations
16.
Kołaczkowski, Marcin, Monika Marcinkowska, Adam Bucki, et al.. (2014). Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia. European Journal of Medicinal Chemistry. 92. 221–235. 27 indexed citations
17.
Bieńkowski, Przemysław, Jerzy Samochowiec, Justyna Pełka-Wysiecka, et al.. (2014). Functional polymorphism of matrix metalloproteinase-9 (MMP9) gene is not associated with schizophrenia and with its deficit subtype. Pharmacological Reports. 67(3). 442–445. 14 indexed citations
18.
Sobów, Tomasz, Jarosław Bogaczewicz, Jakub Ząbek, et al.. (2013). Zaburzenia psychiczne w toczniu rumieniowatym układowym. SHILAP Revista de lepidopterología.
19.
Grzywacz, Anna, et al.. (2012). Family-Based and Case-Control Study of Glutamate Receptor <b><i>GRIK3</i></b> Ser310Ala Polymorphism in Alcohol Dependence. European Addiction Research. 19(1). 55–59. 7 indexed citations
20.
Bieńkowski, Przemysław, Roman Stefański, & Wojciech Kostowski. (1996). Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol. European Journal of Pharmacology. 314(3). 277–280. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Goudie Breakdown of academic impact, for papers by László Lénárd Breakdown of academic impact, for papers by Vijay A. Ramchandani Breakdown of academic impact, for papers by Annette L. Kirchgessner Breakdown of academic impact, for papers by Edwin Zvartau Breakdown of academic impact, for papers by John R. Glowa Breakdown of academic impact, for papers by Andrew Harkin Breakdown of academic impact, for papers by John E. McGeary Breakdown of academic impact, for papers by Gregg D. Stanwood Breakdown of academic impact, for papers by Luis Hernández
Rankless by CCL
2026